Skip to content
DataLookout
Menu

INOCSNCT07200726

The Role of Neuroinflammation on Neurocognitive Outcome in Cardiac Surgery

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 4 words Show 6 more changesShow less
    • Trial completed
    • Final enrollment: 89 participants (planned 80)
    • Primary completion date changed from estimate of Sep 2026 to Oct 26, 2026
    • Study completion date changed from estimate of Oct 2026 to Oct 26, 2026
    • Secondary endpoints: details revised at 9 of 10 entries
    • Site details revised
  2. Notable Enrollment increased: 50 → 80 participantsv3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2025 to Oct 21, 2025
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Incidence of postoperative neurocognitive disorder (PNCD) after cardiac surgery using the NPA.
Timeframe: The NPA will be taken preoperatively and postoperatively on day 40 (+/- 10).

Secondary (10)

Delayed neurocognitive recovery (DNCR)
Postoperative delirium (CAM-ICU)
Postoperative delirium (3D-CAM)
Quality of recovery (QoR-15)
Postoperative muscle strength (HGS)
Show 5 moreShow less
Postoperative fatigue (CFQ)
Health-related quality of life (EQ5D5L)
Subjective sleep quality (PSQI)
Sleeping EEG pattern
Markers of neuroinflammation and neurodegeneration

Arms and interventions

Other: Observational study design - no intervention

Sites

1 site in 1 country

  • Ziekenhuis Oost-LimburgGenk, Limburg, Belgium